These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 17014688)

  • 1. Reduced oxidative damage in ALS by high-dose enteral melatonin treatment.
    Weishaupt JH; Bartels C; Pölking E; Dietrich J; Rohde G; Poeggeler B; Mertens N; Sperling S; Bohn M; Hüther G; Schneider A; Bach A; Sirén AL; Hardeland R; Bähr M; Nave KA; Ehrenreich H
    J Pineal Res; 2006 Nov; 41(4):313-23. PubMed ID: 17014688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraperitoneal melatonin is not neuroprotective in the G93ASOD1 transgenic mouse model of familial ALS and may exacerbate neurodegeneration.
    Dardiotis E; Panayiotou E; Feldman ML; Hadjisavvas A; Malas S; Vonta I; Hadjigeorgiou G; Kyriakou K; Kyriakides T
    Neurosci Lett; 2013 Aug; 548():170-5. PubMed ID: 23748038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin inhibits the caspase-1/cytochrome c/caspase-3 cell death pathway, inhibits MT1 receptor loss and delays disease progression in a mouse model of amyotrophic lateral sclerosis.
    Zhang Y; Cook A; Kim J; Baranov SV; Jiang J; Smith K; Cormier K; Bennett E; Browser RP; Day AL; Carlisle DL; Ferrante RJ; Wang X; Friedlander RM
    Neurobiol Dis; 2013 Jul; 55():26-35. PubMed ID: 23537713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic immunization with a glatiramer acetate derivative does not alter survival in G93A and G37R SOD1 mouse models of familial ALS.
    Haenggeli C; Julien JP; Mosley RL; Perez N; Dhar A; Gendelman HE; Rothstein JD
    Neurobiol Dis; 2007 Apr; 26(1):146-52. PubMed ID: 17276077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additive neuroprotective effects of a histone deacetylase inhibitor and a catalytic antioxidant in a transgenic mouse model of amyotrophic lateral sclerosis.
    Petri S; Kiaei M; Kipiani K; Chen J; Calingasan NY; Crow JP; Beal MF
    Neurobiol Dis; 2006 Apr; 22(1):40-9. PubMed ID: 16289867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocyte growth factor (HGF) attenuates gliosis and motoneuronal degeneration in the brainstem motor nuclei of a transgenic mouse model of ALS.
    Kadoyama K; Funakoshi H; Ohya W; Nakamura T
    Neurosci Res; 2007 Dec; 59(4):446-56. PubMed ID: 17935811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced oxidative stress and the treatment by edaravone in mice model of amyotrophic lateral sclerosis.
    Ohta Y; Nomura E; Shang J; Feng T; Huang Y; Liu X; Shi X; Nakano Y; Hishikawa N; Sato K; Takemoto M; Yamashita T; Abe K
    J Neurosci Res; 2019 May; 97(5):607-619. PubMed ID: 30565312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lipophilic metal chelators DP-109 and DP-460 are neuroprotective in a transgenic mouse model of amyotrophic lateral sclerosis.
    Petri S; Calingasan NY; Alsaied OA; Wille E; Kiaei M; Friedman JE; Baranova O; Chavez JC; Beal MF
    J Neurochem; 2007 Aug; 102(3):991-1000. PubMed ID: 17630988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonergic mechanisms in amyotrophic lateral sclerosis.
    Sandyk R
    Int J Neurosci; 2006 Jul; 116(7):775-826. PubMed ID: 16861147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased internalisation and degradation of GLT-1 glial glutamate transporter in a cell model for familial amyotrophic lateral sclerosis (ALS).
    Vanoni C; Massari S; Losa M; Carrega P; Perego C; Conforti L; Pietrini G
    J Cell Sci; 2004 Oct; 117(Pt 22):5417-26. PubMed ID: 15466883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
    Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
    Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of human sporadic ALS biomarkers in the familial ALS transgenic mSOD1(G93A) mouse model.
    Lilo E; Wald-Altman S; Solmesky LJ; Ben Yaakov K; Gershoni-Emek N; Bulvik S; Kassis I; Karussis D; Perlson E; Weil M
    Hum Mol Genet; 2013 Dec; 22(23):4720-5. PubMed ID: 23836781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis.
    Klivenyi P; Ferrante RJ; Matthews RT; Bogdanov MB; Klein AM; Andreassen OA; Mueller G; Wermer M; Kaddurah-Daouk R; Beal MF
    Nat Med; 1999 Mar; 5(3):347-50. PubMed ID: 10086395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fas small interfering RNA reduces motoneuron death in amyotrophic lateral sclerosis mice.
    Locatelli F; Corti S; Papadimitriou D; Fortunato F; Del Bo R; Donadoni C; Nizzardo M; Nardini M; Salani S; Ghezzi S; Strazzer S; Bresolin N; Comi GP
    Ann Neurol; 2007 Jul; 62(1):81-92. PubMed ID: 17503505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depletion of reduced glutathione enhances motor neuron degeneration in vitro and in vivo.
    Chi L; Ke Y; Luo C; Gozal D; Liu R
    Neuroscience; 2007 Feb; 144(3):991-1003. PubMed ID: 17150307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opposing effects of low and high-dose clozapine on survival of transgenic amyotrophic lateral sclerosis mice.
    Turner BJ; Rembach A; Spark R; Lopes EC; Cheema SS
    J Neurosci Res; 2003 Nov; 74(4):605-13. PubMed ID: 14598305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS.
    Li W; Brakefield D; Pan Y; Hunter D; Myckatyn TM; Parsadanian A
    Exp Neurol; 2007 Feb; 203(2):457-71. PubMed ID: 17034790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-permeable peptide antioxidants as a novel therapeutic approach in a mouse model of amyotrophic lateral sclerosis.
    Petri S; Kiaei M; Damiano M; Hiller A; Wille E; Manfredi G; Calingasan NY; Szeto HH; Beal MF
    J Neurochem; 2006 Aug; 98(4):1141-8. PubMed ID: 16895581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Motor neuron disease: a chemical perspective.
    Wood LK; Langford SJ
    J Med Chem; 2014 Aug; 57(15):6316-31. PubMed ID: 24694032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Memantine prolongs survival in an amyotrophic lateral sclerosis mouse model.
    Wang R; Zhang D
    Eur J Neurosci; 2005 Nov; 22(9):2376-80. PubMed ID: 16262676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.